Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups
- PMID: 29209945
- DOI: 10.1007/s40257-017-0332-7
Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups
Erratum in
-
Author Correction to: Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups.Am J Clin Dermatol. 2018 Jun;19(3):425. doi: 10.1007/s40257-018-0347-8. Am J Clin Dermatol. 2018. PMID: 29453712
Abstract
Psoriasis is a chronic inflammatory skin condition affecting diverse racial/ethnic groups throughout the world. Large population-based studies suggest that psoriasis occurs most often in individuals of European ancestry, followed by black and Hispanic individuals, although the true prevalence of psoriasis in non-white individuals is likely underestimated. Despite similarities in psoriasis between ethnic groups, there are notable differences in the presentation, quality-of-life impact, and treatment of psoriasis with important implications for the management of non-white individuals. Overall, heterogeneity in psoriasis susceptibility alleles, in combination with cultural and socioeconomic factors, may explain these differences. In this article, we review the epidemiology, clinical presentation, genetic polymorphisms, quality-of-life impact, and treatment nuances of psoriasis in patients with skin of color.
Similar articles
-
Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.Am J Clin Dermatol. 2016 Aug;17(4):349-58. doi: 10.1007/s40257-016-0191-7. Am J Clin Dermatol. 2016. PMID: 27113059 Review.
-
Psoriasis & psoriatic therapies.Nurse Pract. 2017 Jul 15;42(7):35-39. doi: 10.1097/01.NPR.0000520419.09460.ad. Nurse Pract. 2017. PMID: 28622256
-
Genital Psoriasis: Impact on Quality of Life and Treatment Options.Am J Clin Dermatol. 2019 Oct;20(5):639-646. doi: 10.1007/s40257-019-00447-5. Am J Clin Dermatol. 2019. PMID: 31313079 Review.
-
[Psoriasis--clinical picture and current therapy].Med Monatsschr Pharm. 2009 Sep;32(9):335-44; quiz 345-6. Med Monatsschr Pharm. 2009. PMID: 19795696 Review. German.
-
Psoriasis in People With Skin of Color: An Evidence-Based Update.Int J Dermatol. 2025 Apr;64(4):667-677. doi: 10.1111/ijd.17651. Epub 2025 Jan 31. Int J Dermatol. 2025. PMID: 39887710 Free PMC article. Review.
Cited by
-
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial.Adv Ther. 2021 Oct;38(10):5253-5269. doi: 10.1007/s12325-021-01836-1. Epub 2021 Sep 2. Adv Ther. 2021. PMID: 34471992 Free PMC article. Clinical Trial.
-
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials.Dermatol Ther (Heidelb). 2021 Oct;11(5):1551-1569. doi: 10.1007/s13555-021-00570-4. Epub 2021 Jul 14. Dermatol Ther (Heidelb). 2021. PMID: 34260044 Free PMC article.
-
Pharmacokinetics and tolerability of apremilast in healthy Korean adult men.Clin Transl Sci. 2021 Jul;14(4):1505-1511. doi: 10.1111/cts.13013. Epub 2021 May 1. Clin Transl Sci. 2021. PMID: 33932093 Free PMC article. Clinical Trial.
-
Patient-Reported and Economic Racial and Ethnic Disparities in Patients with Psoriatic Arthritis: Results from the National Health and Wellness Survey.Rheumatol Ther. 2024 Dec;11(6):1569-1590. doi: 10.1007/s40744-024-00717-7. Epub 2024 Sep 29. Rheumatol Ther. 2024. PMID: 39343841 Free PMC article.
-
Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon?Front Med (Lausanne). 2022 Oct 13;9:1007892. doi: 10.3389/fmed.2022.1007892. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314037 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical